Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 14.

Giudici, F; Bertisch, B; Negro, F; Stirnimann, G; Müllhaupt, B; Moradpour, D; Cerny, A; Keiser, O; Swiss Hepatitis C Cohort Study (2016). Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person-centred approach. Journal of Viral Hepatitis, 23(9):697-707.

Staehelin, C; Keiser, O; Calmy, A; Weber, R; Elzi, L; Cavassini, M; Schmid, P; Bernasconi, E; Furrer, H (2012). Longer term clinical and virological outcome of Sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes, 59(1):79-85.

Clifford, G M; Lise, M; Franceschi, S; Egger, M; Bouchardy, C; Korol, D; Levi, F; Ess, S; Jundt, G; Wandeler, G; Fehr, J; Schmid, P; Battegay, M; Bernasconi, E; Cavassini, M; Calmy, A; Keiser, O; Schöni-Affolter, F (2012). Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. British Journal of Cancer, 106(3):447-452.

Keiser, O; Spycher, B; Rauch, A; Calmy, A; Cavassini, M; Glass, T R; Nicca, D; Ledergerber, B; Egger, M (2012). Outcomes of antiretroviral therapy in the Swiss HIV Cohort Study: Latent class analysis. AIDS and Behavior, 16(2):245-255.

Wandeler, G; Keiser, O; Hirschel, B; Günthard, H F; Bernasconi, E; Battegay, M; Clerc, O; Vernazza, P L; Furrer, H (2011). A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA. PLoS ONE, 6(12):e27903.

Schöni-Affolter, F; Keiser, O; Mwango, A; Stringer, J; Ledergerber, B; Mulenga, L; Bucher, H C; Westfall, A O; Calmy, A; Boulle, A; Chintu, N; Egger, M; Chi, B H (2011). Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: The effect of the competing risk of death in Zambia and Switzerland. PLoS ONE, 6(12):e27919.

Rohrbach, J; Robinson, N; Harcourt, G; Hammond, E; Gaudieri, S; Gorgievski, M; Telenti, A; Keiser, O; Günthard, H F; Hirschel, B; Hoffmann, M; Bernasconi, E; Battegay, M; Furrer, H; Klenerman, P; Rauch, A (2010). Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy. Gut, 59(9):1252-1258.

Franceschi, S; Lise, M; Clifford, G M; Rickenbach, M; Levi, F; Maspoli, M; Bouchardy, C; Dehler, S; Jundt, G; Ess, S; Bordoni, A; Konzelmann, I; Frick, H; Dal Maso, L; Elzi, L; Furrer, H; Calmy, A; Cavassini, M; Ledergerber, B; Keiser, O; Swiss HIV Cohort Study (2010). Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. British Journal of Cancer, 103(3):416-422.

Keiser, O; Spoerri, A; Brinkhof, M W G; Hasse, B; Gayet-Ageron, A; Tissot, F; Christen, A; Battegay, M; Schmid, P; Bernasconi, E; Egger, M (2010). Suicide in HIV-infected individuals and the general population in Switzerland, 1988-2008. American Journal of Psychiatry, 167(2):143-150.

Bellini, C; Keiser, O; Chave, J P; Evison, Jm; Fehr, J; Kaiser, L; Weber, R; Vernazza, P; Bernasconi, E; Telenti, A; Cavassini, M (2009). Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study. HIV Medicine, 10(1):12-18.

Keiser, O; Orrell, C; Egger, M; Wood, R; Brinkhof, M W G; Furrer, H; van Cutsem, G; Ledergerber, B; Boulle, A (2008). Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared. PLoS Medicine, 5(7):e148.

Vo, N T T; Ledergerber, B; Keiser, O; Hirschel, B; Furrer, H; Battegay, M; Cavassini, M; Bernasconi, E; Vernazza, P; Weber, R (2008). Durability and outcome of initial antiretroviral treatments received during 2000-2005 by patients in the Swiss HIV Cohort Study. Journal of Infectious Diseases, 197(12):1685-1694.

Keiser, O; Gayet-Ageron, A; Rudin, C; Brinkhof, M W G; Gremlich, E; Wunder, D; Drack, G; Hirschel, B; de Tejada, B M (2008). Antiretroviral treatment during pregnancy. AIDS, 22(17):2323-2330.

Clifford, G M; Polesel, J; Rickenbach, M; Dal Maso, L; Keiser, O; Kofler, A; Rapiti, E; Levi, F; Jundt, G; Fisch, T; Bordoni, A; De Weck, D; Franceschi, S (2005). Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Journal of the National Cancer Institute, 97(6):425-432.

This list was generated on Mon Sep 25 00:24:22 2017 CEST.